Gözde Ertürk Zararsız

ORCID: 0000-0002-5495-7540 · 1 paper in corpus

article 2025

The Effect of Bazedoxifene and Fulvestrant for Preventing Ovarian Hyperstimulation Syndrome: An Experimental Study

·doi:10.3390/jcm14207435

Fulvestrant and bazedoxifene may reduce OHSS severity by lowering ascites formation and weight gain. These agents could be potential therapeutic candidates for OHSS with appropriate timing and dosage.